Plain-English translation of NCT07380217 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a new mechanical heart support device called the PulseCath iVAC 2L can help keep patients safe during high-risk heart procedures. The device is a small pump that temporarily helps your heart do its job during the procedure. Researchers want to see if using this device reduces complications and improves outcomes compared to standard care without the device.
Patients with severely weakened hearts who need complex coronary artery procedures face high risks during and after the procedure. This medication could help prevent dangerous drops in blood pressure and heart function during the procedure, but doctors need to know if the benefits outweigh any risks.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either receive the new heart support device during your scheduled coronary procedure or to proceed with standard care. If you receive the device, it will be placed through a small catheter in your leg before the procedure begins and removed afterward. The study involves about 98 patients across multiple centers, and your doctors will monitor your heart function and watch for any complications during and after the procedure.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Netherlands